The Effect of Hippotherapy on The Development of Life Satisfaction, Health Literacy and Healthism Attitude of Young Adults After Cancer Treatment

December 9, 2024 updated by: Betül Çakmak

The Effect of Hippotherapy on The Development of Life Satisfaction, Health Literacy and Healthism Attitude of Young Adults After Cancer Treatment: Randomized Controlled Experimental Research

This research aims to evaluate the impact of hippotherapy on life satisfaction, health literacy, and health culture among young adults who have undergone cancer treatment. The study underscores the importance of providing support to patients post-cancer treatment. While the literature extensively supports the use of animal-assisted interventions in nursing care plans and practices, there is a notable absence of studies examining the holistic effects of hippotherapy on cancer survivors, both nationally and globally. Given that nurses play a pivotal role in the prevention, diagnosis, treatment, and rehabilitation stages of all diseases, and strive to enhance patient quality of life through comprehensive care, the findings of this project are expected to not only bolster the visibility and professional efficacy of nurses but also inspire similar future research. The research tools employed will determine how complementary supportive practices influence the life satisfaction, health literacy, and health culture of young adults during critical life-shaping periods. These results could provide significant evidence of the nurse's role in patient education, support, and overall care improvement.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Not yet recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Cancer is one of the most important diseases that threaten human health today. It is predicted that the number of cancer survivorship will increase in the future with advances in diagnosis, treatment and care approaches. It is stated that after cancer treatment, individuals have difficulty in continuing treatment due to reasons such as post-treatment side effects, economic and social problems, and their quality of life is negatively affected. It is stated that cancer diagnosis and treatment processes can be observed more specifically in young adults compared to other age groups. It is reported that especially young adults with cancer experience higher levels of depression, worse quality of life and deterioration in body image during treatment, and have difficulty achieving goals related to social, business and academic life. For this reason, it is thought that health professionals have important roles and responsibilities in supporting the lives of young adults, especially after cancer treatment. Nurses should be able to determine the psychosocial needs of individuals, support them in creating positive behavioral changes, empower individuals about coping methods, and take an active role in improving the quality of life of individuals. Complementary methods are one of the approaches frequently included in nurses' care content. Animal-assisted interventions, which are one of the complementary methods, are used at a very limited level in our country. In the Nursing Interventions Classification (NIC) system, it is stated that Animal Assisted Practices contribute positively to the physical, spiritual and social recovery of the individual. Hippotherapy, also known as horse-assisted therapy, is one of the animal-assisted therapies. They are regularly scheduled activities implemented to provide functionality to individuals' lives and contribute to the improvement of their general health status. With these activities, it is aimed to improve the perception of individuals in the sensory field, to strengthen self-confidence, to relax, to provide peace of mind, courage and self-confidence, to remove fear and discouragement, to eliminate distraction, supporting group speaking training, increasing the ability of the individual to express himself, to provide social support for each individual. It aims to ensure that they are always ready for communication. This project will examine the effect of Hippotherapy on life satisfaction, health literacy and the development of a healthy culture of young adult individuals after cancer treatment. The sample of the research will consist of 40 individuals between the ages of 18-35 who have been diagnosed with cancer and completed their treatment. A life satisfaction scale, health literacy scale, health culture scale and qualitative interview form will be used to collect data in the research. In the implementation of the research, hippotherapy implementation consisting of a total of 5 stations created by the researchers, lasting 30 minutes individually, will be applied to the individuals in the intervention group for 8 weeks, with the participation of the riding coaches. Research data will be collected by the researchers before the implementation (0th), in the 4th and 8th weeks of the implementation.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
40

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Ankara, Turkey, 06010
        • Ankara Yıldırım Beyazıt University, Faculty of Health Sciences, Department of Nursing

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Between the ages of 18-30
  • He has been diagnosed with cancer and his treatment has been completely completed.
  • Least literate
  • Pregnant and non-puerperal
  • Does not have any physical or cognitive disabilities
  • No visual or auditory disabilities

Exclusion Criteria:

  • Individuals who cannot participate in all hippotherapy activities

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: The group in which hippotherapy activity will be applied
In the implementation of the experimental group, hippotherapy implementation consisting of a total of 5 stations created by the researchers, lasting 30 minutes individually, will be applied to the individuals in the intervention group for 8 weeks, with the participation of the riding coaches. Research data will be collected by the researchers before the implementation (0th), in the 4th and 8th weeks.
Other: Hippotherapy
Hippotherapy, also known as horse-assisted therapy, is a form of animal-assisted therapy. It consists of regularly scheduled sessions designed to enhance functionality in individuals' lives and contribute to their overall health improvement.
Other Names:
  • activity with horse
No Intervention: The group in which hippotherapy activity will not be applied
In the control group, no interventions will be administered to the participants; data collection will occur solely at the outset (week 0) and at the research period's conclusion (week 8). After completing the main research activities, participants in the control group will be invited to an activity involving horses.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Change in the health literacy level of young adults with hippotherapy effectiveness
Time Frame: 12 weeks
The Health Literacy Scale consists of three sub-dimensions: Functional Health Literacy (Items 1, 2, 3, 4, 5), Interactive Health Literacy (Items 6, 7, 8, 9, 10), and Critical Health Literacy (Items 11, 12, 13, 14). Each item on the scale is scored from "strongly disagree" (1 point) to "strongly agree" (5 points) on a five-point Likert scale. Scores on the scale range from 14 to 70. Higher total scores indicate an increase in the level of health literacy. The Cronbach's alpha reliability coefficient of the Health Literacy Scale is 0.85.
12 weeks
Change in the life satisfaction level of young adults with hippotherapy effectiveness
Time Frame: 12 weeks
The Life Satisfaction Scale consists of a total of 21 items, one of which is reversed. The scale is designed as a five-point Likert type (1=Not at all suitable, 2=Not suitable, 3=Somewhat suitable, 4=Suitable, 5=Completely suitable). Item 6 of the scale is scored in reverse. The possible scores from the Life Satisfaction Scale range from 21 to 105. Higher scores on the scale indicate that the individual has positive perceptions regarding their own life. The scale has five sub-dimensions: the first sub-dimension is general life satisfaction (Items 1, 2, 3, 4, 5, and 6); the second is relationship satisfaction (Items 7, 8, 9, 10, and 11); the third is self-satisfaction (Items 12, 13, 14, and 15); the fourth is social environment satisfaction (Items 16, 17, and 18); and the fifth is job satisfaction (Items 19, 20, and 21). The Cronbach's alpha reliability coefficient of the scale is calculated as .89.
12 weeks
Change in the Healthism Attitude level of young adults with hippotherapy effectiveness
Time Frame: 12 weeks
The Healthism Attitude scale consists of 14 items, each rated from "completely disagree" (1 point) to "completely agree" (5 points) on a five-point Likert scale. The scale has two sub-dimensions: the Critique of Individual Actions (Items 1, 2, 3, 4, 5, 6, 7, 8) and Judgment sub-dimension (Items 9, 10, 11, 12, 13, 14). As scores on the scale increase, so does the level of knowledge about the culture of being healthy. The internal consistency coefficient of the Healthism Attitude scale is found to be .891.
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Betül Çakmak

Collaborators

Collaborators

An organization other than the sponsor that provides support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting.
Ankara Yildirim Beyazıt University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
December 1, 2024

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
June 30, 2025

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
October 1, 2025

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
June 10, 2024

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 14, 2024

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
June 21, 2024

Study Record Updates

Last Update Posted (Estimated)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
December 12, 2024

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
December 9, 2024

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
December 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 18.08.2024

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

It will not be shared with other researchers.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer

Clinical Trials on Hippotherapy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings